Karlsson D, Fallarero A, Shinde P, Anju CP, Busygin I, Leino R, Mohan CG, Vuorela P (2014) <br />Chemical modifications of cinchona alkaloids lead to enhanced inhibition of human butyrylcholinesterase<br /><i>Nat Prod Commun</i> <b>9</b>: 455<br /><br />Prinz M, Parlar S, Bayraktar G, Alptuzun V, Erciyas E, Fallarero A, Karlsson D, Vuorela P, Burek M, Forster C, Turunc E, Armagan G, Yalcin A, Schiller C, Leuner K, Krug M, Sotriffer CA, Holzgrabe U (2013) <br />1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BCHE, and amyloid-beta aggregation crossing the blood-brain barrier<br /><i>Eur J Pharm Sci</i> <b>49</b>: 603<br /><br />Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P (2012) <br />Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: The case of chelerythrine<br /><i>Bioorganic & Medicinal Chemistry</i> <b>20</b>: 6669<br /><br />Karlsson D, Fallarero A, Brunhofer G, Guzik P, Prinz M, Holzgrabe U, Erker T, Vuorela P (2012) <br />Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation<br /><i>Eur J Pharm Sci</i> <b>45</b>: 169<br /><br />Karlsson D, Fallarero A, Brunhofer G, Mayer C, Prakash O, Mohan CG, Vuorela P, Erker T (2012) <br />The exploration of thienothiazines as selective butyrylcholinesterase inhibitors<br /><i>Eur J Pharm Sci</i> <b>47</b>: 190<br /><br />Gupta S, Fallarero A, Jarvinen P, Karlsson D, Johnson MS, Vuorela PM, Mohan CG (2011) <br />Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques<br /><i>Bioorganic & Medicinal Chemistry Lett</i> <b>21</b>: 1105<br /><br />